Vietnam News

Vietnam approves emergency use of Cuba’s Covid vaccine

Print Friendly, PDF & Email

The Ministry of Health on Friday granted emergency approval of Cuba’s Abdala Covid-19 vaccine.

The Abdala vaccine, of which the technical name is CIGB-66, is developed by the Center for Genetic Engineering and Biotechnology.

The vaccine employs a traditional approach by using a part of the spike protein, which the virus uses to bind to human cells, to build up the immune reaction.

Cuba approved emergency use of the Abdala vaccine on July 9 after manufacturers announced in June that the vaccine was more than 92 percent effective when three doses were given.

Abdala has made the eighth Covid-19 vaccine approved for emergency use in Vietnam aside from the U.K.’s AstraZeneca, the U.S.’s Johnson & Johnson, Moderna and Pfizer-BioNTech, Russia’s SputnikV, China’s Sinopharm and the UAE’s Hayat-Vax.

More than 33 million of the nation’s 96-million population have been vaccinated, with over 6.18 million getting two doses.

By Le Nga – – September 18, 2021

Translate / Dịch

En continuant à utiliser ce site, vous acceptez l’utilisation de traceurs (cookies). Plus d’informations

En poursuivant la visite de ce site, vous acceptez l’utilisation de traceurs (cookies) vous permettant d'optimiser votre navigation. Aucune information sur votre utilisation de ce site ne sera partagée auprès de quelconques médias sociaux, de sociétés commerciales ou d'agences de publicité et d'analyse. Cliquer sur le bouton "Accepter", équivaut à votre consentement.